| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3904195 | Urology | 2010 | 7 Pages |
Abstract
Combination therapy using SAHA and ritonavir inhibited the proliferation of renal cancer cells effectively, perhaps by inhibiting both histone deacetylase function and expression. It might be a useful new regimen for treating renal cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Akinori Sato, Takako Asano, Akio Horiguchi, Keiichi Ito, Makoto Sumitomo, Tomohiko Asano,